Clinical trial
Treatment of Executive Dysfunction in Parkinson's Disease
NCT00286949
Study timeline
Study start (actual)2005-01-06Date precision: day
Registry last updated2017-11-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Parkinson's Diseaseunresolved
Interventions
AtomoxetineDRUG · verified · RxNorm: atomoxetine
Sponsors & collaborators
Johns Hopkins Universitylead sponsor
Eli Lilly and Companycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00286949 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.